CP has also shown efficacy against psoriasis, an inflammatory skin condition with abnormal keratinocyte activity that exhibit aberrant MAPK, PI3K/Akt, STAT3, and NFκB pathway [282]. The gene discussed is AKT1; the disease is psoriasis.